CEPI Funds $6.2M for mRNA-Based Rift Valley Fever Vaccine Trials

A $6.2m grant from the Coalition for Epidemic Preparedness Innovations (CEPI) went to South African biotech Afrigen Biologics for leadingIFT Valley fever mRNA vaccine development. Thanks to funding from CEPI Afrigen researchers will collaborate with the International Vaccine Institute (IVI) to progress the mRNA candidate through animal trials and human safety tests leading to a Phase I clinical trial. Scientists […]